Diagnostic Wait Time Important in DLBCL With High IPI Score
July 10, 2019
Researchers looked at the effect of diagnostic wait time on survival outcomes for patients with diffuse large B-cell lymphoma.
News
Novel Conjugate Shows Promise in HER2-Expressing Cancers
July 9, 2019
Researchers tested the novel antibody-drug conjugate trastuzumab duocarmazine in patients with heavily pretreated HER2-expressing metastatic cancers, including breast cancer.
Hospice Associated With Cost Savings at End of Life for Myeloma Patients
July 8, 2019
A new study found that enrolling appropriate patients with multiple myeloma into hospice may have cost implications.
Using Patient-Reported Outcomes to Reflect Post-Prostatectomy Sexual Function
July 8, 2019
A new study used two patient-reported measures of sexual function following radical prostatectomy to assess sexual interest and satisfaction in men with prostate cancer.
Longer Travel Time to Cancer Care Site May Mean Higher Costs
July 3, 2019
This study adds to the evidence that the decline in access to local care due to the shuttering of rural hospitals and community cancer clinics adversely affects cancer patients.
Meta-Analysis Shows Importance of HPV Vaccines
July 2, 2019
Significant reductions in several strains of HPV and HPV-associated diseases have occurred in the up to 8 years of follow-up since implementation of the girls-only HPV vaccination.
Predicting Carfilzomib-Related Cardiovascular Adverse Events in Myeloma
July 2, 2019
Researchers conducted a study to define risk factors for cardiovascular adverse events in patients with multiple myeloma who were taking proteasome inhibitors.
Is MRI or Mammography the Better Approach to Breast Cancer Screening?
July 1, 2019
The FaMRIsc trial was designed to compare MRI and mammography screening in women with familial risk but no known specific driver mutation.
ASCO Updates Guidelines for Early Breast Cancer Based on TAILORx, MINDACT Trials
July 1, 2019
ASCO has updated its endorsement of a guideline regarding adjuvant systemic therapy decisions for early-stage operable breast cancer.
The Case for Tumor and Germline Testing in Endometrial Cancer Patients
June 27, 2019
A new study reinforces the need for universal mismatch repair protein immunohistochemistry screening of tumors from endometrial cancer patients, as well as germline genetic testing in accordance with guidelines.
